Pediatr. praxi. 2015;16(1):45-47

During childhood unrecognized congenital heart defect in patient with Turner syndrome, and its implications

MUDr.Eva Klásková1, MUDr.Zbyněk Tüdös, Ph.D.2, MUDr.Sabina Kaprálová1, doc.MUDr.Jiřina Zapletalová, Ph.D.1
1 Dětská klinika LF UP a FN v Olomouci
2 Radiologická klinika LF UP a FN v Olomouci

Congenital heart disease affects approximately 50 % of individuals with Turner syndrome (TS). Bicuspid aortic valve, aortic coarctation,

ascending aorta dilatation and arterial hypertension are important risk factors for life-threatening aortic dissection or rupture. Authors

discuss the importance of a careful cardiac examination including cardiac magnetic resonance imaging study and life-long follow-up

by experienced cardiologist in TS patients, and point out high maternal mortality and morbidity during pregnancy. They present a case

report of woman with TS and the above-mentioned in childhood unrecognized congenital heart defects that underwent infertility treatment

without preconceptional counselling focused on cardiovascular risk for aortic dissection.

Keywords: Turner syndrome, congenital heart defect, bicuspid aortic valve, aortic coarctation, aortic dissection, pregnancy

Published: February 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Klásková E, Tüdös Z, Kaprálová S, Zapletalová J. During childhood unrecognized congenital heart defect in patient with Turner syndrome, and its implications. Pediatr. praxi. 2015;16(1):45-47.
Download citation

References

  1. Zapletalová J, Lebl J, Šnajderová M. Turnerův syndrom. Praha: Galen 2003.
  2. Stochholm K, Svend J, Knud J, et al. Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome. J Clin Endocrinol Metabolism 2006; 91(10): 3897-3902. Go to original source... Go to PubMed...
  3. Bondy CA. Congenital cardiovascular disease in Turner syndrome. Congenit Heart Dis 2008; 3(1): 2-15. Go to original source... Go to PubMed...
  4. Mazzanti L, Prandstraller D, Fattori R, et al. Monitoring of congenital heart disease (CHD) and aortic dilatation in Turner syndrome: Italian experience. International Congress Series 2006; 1298: 123-130. Go to original source...
  5. Loscalzo M, Van Phillip L, Ho V, et al. Association Between Fetal Lymfedema and Congenital Cardiovascular Defects in Turner Syndrome. Pediatrics 2005; 115(3): 732-735. Go to original source... Go to PubMed...
  6. Völkl TMK, Degenhardt K, Koch A, et al. Cardiovascular Anomalies in Children and Young Adults with Ullrich-Turner syndrome - The Erlagen Experience. Clin Cardiol 2005; 28(2): 88-92. Go to original source... Go to PubMed...
  7. Sachdev V, Matura LA, Sidenko S, et al. Aortic valve disease in Turner syndrome. JACC 2008; 51(19): 1904-1909. Go to original source... Go to PubMed...
  8. Ho VB, Bakalov VK, Cooley M, et al. Major Vascular Anomalies in Turner Syndrome: Prevalence and Magnetic Resonance Angiographic Features. Circulation 2004; 110(12): 1694-1700. Go to original source... Go to PubMed...
  9. Ostberg JE, Brookes JAS, McCarthy C, et al. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endokrinol Metabolism 2004; 80(12): 5966-5871. Go to original source... Go to PubMed...
  10. Matura LA, Ho VB, Rosing DR, Bondy CA. Aortic dilatation and dissection in Turner syndrome. Circulation 2007; 116(15): 1663-1670. Go to original source... Go to PubMed...
  11. Lanzarini L, Larizza D, Prete G, et al. Prospective evaluation of aortic dimensions in Turner syndrome: A 2-dimensional echocardiographic study. J Am Soc Echocardiogr 2007; 20(3): 307-313. Go to original source... Go to PubMed...
  12. Carlson M, Silberbach M. Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature. J Med Genet 2007; 44(12): 745-749. Go to original source... Go to PubMed...
  13. Carlson M, Airhart N, Lopez L. Moderate Aortic Enlargement and Bicuspid Aortic Valve Are Associated With Aortic Dissection in Turner Syndrome. Circulation 2012; 126(18): 2220-2226. Go to original source... Go to PubMed...
  14. Karnis MF, Zimon AE, Lalwani SI, et al. Risk of death in pregnancy achieved through oocyte donation in patient with Turner syndrome: a national survey. Fertil Steril 2003; 80(3): 498-501. Go to original source... Go to PubMed...
  15. Chevalier N, Letur H, Lelannou D, et al. Materno-fetal Cardiovascular Complications in Turner syndrome after Oocyte Donation: Insufficient Prepregnancy Screening and Pregnancy Follow-up Are Associated with Poor Outcome. J Clin Endocrinol Metabolism 2011; 96(2): e260-e267. Go to original source... Go to PubMed...
  16. Hadnott TN, Gould HN, Gharib AM, et al. Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertil Steril 2011; 95(7): e1-e3. Go to original source... Go to PubMed...
  17. Hagman A, Loft A, Wennerholm UB, et al. Obstetrics and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Hum Reprod 2013; 28(6): 1598-1609. Go to original source... Go to PubMed...
  18. Bryman I, Sylvén L, Berntorp K, et al. Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil Steril 2011; 95(8): 2507-2510. Go to original source... Go to PubMed...
  19. Practice Committee of the American Society for Reproductive Medicine, American Society for Reproductive Medicine, Birmingham, Alabama. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 2012; 97(2): 282-284.
  20. Cabanes L, Chalas C, Christin-Maitre S, et al. Turner syndrome and pregnancy: a clinical practice. Recommendation for the management of patients with Turner syndrome before and during pregnancy. Eur J Obstet Gynecol Reprod Biol 2010; 152(1): 18-24. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.